99 related articles for article (PubMed ID: 10835604)
1. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5.
Mirzabekov T; Kontos H; Farzan M; Marasco W; Sodroski J
Nat Biotechnol; 2000 Jun; 18(6):649-54. PubMed ID: 10835604
[TBL] [Abstract][Full Text] [Related]
2. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
Yang J; Liu CQ
Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
[TBL] [Abstract][Full Text] [Related]
5. Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4.
Seitz M; Rusert P; Moehle K; Trkola A; Robinson JA
Chem Commun (Camb); 2010 Nov; 46(41):7754-6. PubMed ID: 20830376
[TBL] [Abstract][Full Text] [Related]
6. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.
Babcock GJ; Mirzabekov T; Wojtowicz W; Sodroski J
J Biol Chem; 2001 Oct; 276(42):38433-40. PubMed ID: 11489906
[TBL] [Abstract][Full Text] [Related]
7. Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization.
Hu Q; Trent JO; Tomaras GD; Wang Z; Murray JL; Conolly SM; Navenot JM; Barry AP; Greenberg ML; Peiper SC
J Mol Biol; 2000 Sep; 302(2):359-75. PubMed ID: 10970739
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Aug; 286(1):41-7. PubMed ID: 11485305
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes.
Singh AK; Jiang Y; Gupta S
Alcohol; 2007 Dec; 41(8):591-606. PubMed ID: 17980997
[TBL] [Abstract][Full Text] [Related]
10. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.
Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S
Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800
[TBL] [Abstract][Full Text] [Related]
11. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
[TBL] [Abstract][Full Text] [Related]
12. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis.
Yao Q; Compans RW; Chen C
Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813
[TBL] [Abstract][Full Text] [Related]
13. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
14. Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.
Nisius L; Rogowski M; Vangelista L; Grzesiek S
Protein Expr Purif; 2008 Oct; 61(2):155-62. PubMed ID: 18588983
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
16. NMR analyses of the interaction between CCR5 and its ligand using functional reconstitution of CCR5 in lipid bilayers.
Yoshiura C; Kofuku Y; Ueda T; Mase Y; Yokogawa M; Osawa M; Terashima Y; Matsushima K; Shimada I
J Am Chem Soc; 2010 May; 132(19):6768-77. PubMed ID: 20423099
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor.
Mirzabekov T; Bannert N; Farzan M; Hofmann W; Kolchinsky P; Wu L; Wyatt R; Sodroski J
J Biol Chem; 1999 Oct; 274(40):28745-50. PubMed ID: 10497246
[TBL] [Abstract][Full Text] [Related]
18. Recombinant proteoliposomes prepared using baculovirus expression systems.
Tsumoto K; Yoshimura T
Methods Enzymol; 2009; 465():95-109. PubMed ID: 19913163
[TBL] [Abstract][Full Text] [Related]
19. Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.
Zhukovsky MA; Basmaciogullari S; Pacheco B; Wang L; Madani N; Haim H; Sodroski J
PLoS One; 2010 Oct; 5(10):e13249. PubMed ID: 20967243
[TBL] [Abstract][Full Text] [Related]
20. Analysis of recombinant and native CD4 by one- and two-dimensional gel electrophoresis.
Lynch GW; Dearden M; Sloane AJ; Humphery-Smith I; Cunningham AL
Electrophoresis; 1996 Jan; 17(1):227-34. PubMed ID: 8907546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
